Adrian Ion Bot serves as Executive at Cartesian Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Adrian Ion Bot has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 16, 2025 involved receiving (via award) 5,800 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 16, 2025 | RNAC | $0 | Award | 5,800 | $N/A | Discretionary |
Adrian Ion Bot currently holds 5,800 shares of Cartesian Therapeutics, Inc. (RNAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adrian Ion Bot has been a net neutral trader of RNAC stock. They have purchased $0 and sold $0 worth of shares.
Adrian Ion Bot's most recent insider trade was on Dec 16, 2025, when they sold 5,800 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted